Primary Mediastinal Large B-cell Lymphoma With Cardiac Infiltration and Complete Atrioventricular Block: A Case Report

Primary mediastinal large B-cell lymphoma (PMBCL) predominantly affects young adults and typically presents as a bulky anterior mediastinal mass. Cure rates with first-line immunochemotherapy are high, but relapse involving the heart carries a guarded prognosis. We describe a woman diagnosed at age 20 with a 15.1 × 14.1 × 14.8 cm anterior mediastinal mass, a 20-kg weight loss, and a lactate dehydrogenase level of 490 U/L. Cervical lymph node biopsy showed diffuse large B-cell lymphoma (CD20- and PAX5-positive, focal CD23- and CD30-, CD15-negative, Ki-67 approximately 40%), which was classified as primary mediastinal. She received six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). End-of-treatment PET/CT showed residual uptake above liver uptake (Deauville score 4), which was interpreted at multidisciplinary review as possibly inflammatory, and she was kept under surveillance. Approximately 14 months after treatment, PET/CT showed a maximum standardized uptake value of 25.1 with enlargement of the mass, but surgical biopsy revealed only hyalinized fibrous tissue, with no lymphomatous infiltration on immunohistochemistry. Approximately 26 months after diagnosis, she was admitted with ascites and lower-limb edema. Echocardiography showed a mass infiltrating the right atrium, the right ventricular free wall, and the left atrium, with a mean gradient of 12 mmHg across a narrow right atrioventricular passage. A CT-guided biopsy confirmed PMBCL (Ki-67 approximately 80%); the final report was released after her death. After a prephase with cyclophosphamide, vincristine, and prednisone, she developed complete atrioventricular block (CAVB), attributed to tumor involvement, and no transvenous or epicardial pacing route was feasible. On the 12th day after admission, she developed respiratory failure and cardiorespiratory arrest with return of spontaneous circulation; gemcitabine and oxaliplatin were administered afterwards, and she died the following day of refractory shock, clinically attributed to a cardiogenic mechanism, at age 22. This case report illustrates the limited negative predictive value of biopsy in densely fibrotic residual mediastinal masses, the prognostic relevance of an incomplete metabolic response at the end of first-line therapy, and the therapeutic dilemma of CAVB associated with cardiac lymphoma, where chemotherapeutic cytoreduction is both a potentially reversing therapy and a hemodynamic risk.

Authors

Publication Details

Journal
Cureus
Published
2026-11-21
DOI
https://doi.org/10.7759/cureus.120060
Primary Topic
Cardiac tumors and thrombi
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Primary Mediastinal Large B-cell Lymphoma With Cardiac Infiltration and Complete Atrioventricular Block: A Case Report

Marcelo Gustavo Lopes, Geraldo Zanotelli Neto, José Antônio Rocha Gontijo
Cureus
Cardiac tumors and thrombi
article

Primary Mediastinal Large B-cell Lymphoma With Cardiac Infiltration and Complete Atrioventricular Block: A Case Report

Marcelo Gustavo Lopes, Geraldo Zanotelli Neto, José Antônio Rocha Gontijo
article en

Abstract

Primary mediastinal large B-cell lymphoma (PMBCL) predominantly affects young adults and typically presents as a bulky anterior mediastinal mass. Cure rates with first-line immunochemotherapy are high, but relapse involving the heart carries a guarded prognosis. We describe a woman diagnosed at age 20 with a 15.1 × 14.1 × 14.8 cm anterior mediastinal mass, a 20-kg weight loss, and a lactate dehydrogenase level of 490 U/L. Cervical lymph node biopsy showed diffuse large B-cell lymphoma (CD20- and PAX5-positive, focal CD23- and CD30-, CD15-negative, Ki-67 approximately 40%), which was classified as primary mediastinal. She received six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). End-of-treatment PET/CT showed residual uptake above liver uptake (Deauville score 4), which was interpreted at multidisciplinary review as possibly inflammatory, and she was kept under surveillance. Approximately 14 months after treatment, PET/CT showed a maximum standardized uptake value of 25.1 with enlargement of the mass, but surgical biopsy revealed only hyalinized fibrous tissue, with no lymphomatous infiltration on immunohistochemistry. Approximately 26 months after diagnosis, she was admitted with ascites and lower-limb edema. Echocardiography showed a mass infiltrating the right atrium, the right ventricular free wall, and the left atrium, with a mean gradient of 12 mmHg across a narrow right atrioventricular passage. A CT-guided biopsy confirmed PMBCL (Ki-67 approximately 80%); the final report was released after her death. After a prephase with cyclophosphamide, vincristine, and prednisone, she developed complete atrioventricular block (CAVB), attributed to tumor involvement, and no transvenous or epicardial pacing route was feasible. On the 12th day after admission, she developed respiratory failure and cardiorespiratory arrest with return of spontaneous circulation; gemcitabine and oxaliplatin were administered afterwards, and she died the following day of refractory shock, clinically attributed to a cardiogenic mechanism, at age 22. This case report illustrates the limited negative predictive value of biopsy in densely fibrotic residual mediastinal masses, the prognostic relevance of an incomplete metabolic response at the end of first-line therapy, and the therapeutic dilemma of CAVB associated with cardiac lymphoma, where chemotherapeutic cytoreduction is both a potentially reversing therapy and a hemodynamic risk.

Cureus
Cardiac tumors and thrombi
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon